Stem Cell 2018 is to be held on 21th June,2018

21-22 June 2018 ∣ Porto, Portugal

Website: https://biotechpharmasummit.com/index.php/event/stem-cell-2018/

 

About Conference:

On 21 & 22 June 2018, Porto will host the BioTech Pharma Summit: Stem Cell 2018 conference. This year’s event brings together leading scientists, researchers, professors, delegates across the continents it’s designed for those with an interest in translational medicine, and will highlight research and advances in the field of stem cells and engineering innovations that could improve translational research process.

Why to Attend?

The BioTech Pharma Summit: Stem Cell 2018 will provide information on cutting-edge developments in all areas of stem cell research from bench to bedside, including the biology, medicine, applications, regulations, product development, and the commercialization of stem cells.

Target Audience:

• Stem Cell Biology
• Regenerative Medicine
• Cell Engineering
• Immune Deficiencies
• Stem Cell Manufacturing
• Embryonic and iPSC Stem Cells
• Tissue Engineering
• Technology Transfer
• Cell Line Development
• Regulatory Affairs
• Biomedical Engineering
• Clinical Development
• Bioprocess Development
• Stem Cell Commercialisation
• Cell Reprogramming & Engineering

 

Conference Highlights:

• Advances in Adult Stem Cell Research
• Alpha Clinic: Near and far horizons for regenerative medicine
• Stem Cell Therapy and Tissue Engineered Products
• Advances in Pluripotent Stem Cell Research
• Stem Cells for Drug Discovery and Disease Modeling
• Manufacturing and Scalable Processes for Cell Therapy
• Adipose tissue & SVF in the clinic
• Stem Cells and Regenerative Medicine at the Point of Care
• Establishing a Federal Registry for regenerative cell therapies
• Partnering between Industry, Academia and CROs to Advance Research
• Macro trends in investor, pharma and regulatory environments
• How to capitalize on the future of state funding for stem cell research?
• Regulatory and Funding Challenges
• Examining trial designs and the latest data for product candidates based on cord blood and perinatal stem cells
• Analyzing evolving public and family cord blood and perinatal stem cell banking business models worldwide

 

Contact us

 

Diogo Lino Ribeiro

Tel: +351 915 239 640

Email: diogo.ribeiro@epmgroup.org